KLRK1 and esophageal squamous cell carcinoma: In this study, we first demonstrated that NKG2D CAR-T cells were able to specifically recognize and kill NKG2DL-expressing ESCC cell lines in vitro, and the immunological response was dose-dependent and NKG2D signal-dependent.